首页> 外文OA文献 >A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

【2h】

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

机译：I / II阶段临床试验，以评估白藜芦醇的疗效，以防止对Covid19影响的血液学患者呼吸压力不全进展：随机对照试验的研究方案的结构化概述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G. Moreno-González; A. Mussetti; A. Albasanz-Puig; I. Salvador; A. Sureda; C. Gudiol; R. Salazar; M. Marin; M. Garcia; V. Navarro; I. de la Haba Vaca; E. Coma; G. Sanz-Linares; X. Dura; S. Fontanals; G. Serrano; C. Cruz; R. Mañez;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial [J] . Sobha Sivaprasad, Geoffrey Arden, A T Prevost, Trials . 2014,第1期

机译：一项多中心III期随机对照单掩盖临床试验，评估了遮光膜在预防早期糖尿病性黄斑水肿（CLEOPATRA）中预防黑暗适应的临床疗效和安全性：一项随机对照试验的研究方案
2. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial [J] . Miguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acu?a-Castroviejo, Trials . 2020,第1期

机译：II期，单中心，双盲，随机安慰剂对照试验，用于探讨静脉内褪黑激素在Covid-19患者中录取重症监护单元（Melcovid研究）的疗效和安全性：研究方案的结构化概述对于随机对照试验
3. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial [J] . J. P. Desilles, C. Gregoire, C. Le Cossec, Trials . 2020,第1期

机译：SARS-COV-2诱导的急性呼吸窘迫综合征（ARDS）患者雾化气膜内疣蛋白酶ALFA管理的疗效和安全性：随机对照试验的研究方案的结构化概述
4. Cluster Randomised Controlled Trial of a Mobile Monitoring and Feedback Tool Embedded in a Counselling Protocol to Stimulate Physical Activity in Chronically Ill Patients Study protocol of the It's LiFe! RCT [C] . Sanne van der Weegen, Huibert Tange, Trudy van der Weijden, International Conference on eHealth, Telemedicine, and Social Medicine . 2015

机译：集群随机对照试验的移动监测和反馈工具嵌入辅导议定书中，以刺激其生命的慢性病患者的体育活动！ RCT.
5. Evaluation of a randomized clinical trial of a psychoeducational intervention on long-term quality of life, negative affect, progression and survival in head and neck cancer patients. [D] . Trevino, Lara A. 2011

机译：心理教育干预对头颈部癌症患者的长期生活质量，负面影响，进展和生存的随机临床试验评估。
6. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial [O] . G. Moreno-González, A. Mussetti, A. Albasanz-Puig, 2021

机译：I / II阶段临床试验以评估白藜芦醇的疗效以防止对Covid19影响的血液学患者呼吸压力不全进展：随机对照试验的研究方案的结构化概述
7. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA):study protocol for a randomised controlled trial [O] . Sivaprasad, Sobha, Arden, Geoffrey, Prevost, Toby, 2014

机译：一项多中心III期随机对照单掩盖临床试验，评估遮光膜在预防早期糖尿病性黄斑水肿（CLEOPATRA）中的适应性和预防黑暗适应性的临床疗效和安全性：一项随机对照试验的研究方案

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅